object
review
laboratori
clinic
evid
medicin
valu
zinc
treatment
common
cold
data
sourc
publish
articl
identifi
medlin
use
search
term
zinc
rhinoviru
pertin
subject
head
addit
sourc
identifi
bibliographi
retriev
articl
studi
select
author
data
extract
author
data
synthesi
human
rhinovirus
attach
nasal
epithelium
via
intracellular
adhes
receptor
caus
cold
ionic
zinc
base
electr
charg
also
affin
receptor
site
may
exert
antivir
effect
attach
receptor
rhinoviru
structur
nasal
epitheli
cell
clinic
test
zinc
treatment
common
cold
inconsist
primarili
studi
design
blind
lozeng
content
earli
formul
lozeng
also
unpalat
three
trial
similar
studi
design
methodolog
efficaci
assess
zinc
effect
significantli
shorten
durat
common
cold
administ
within
hour
onset
symptom
recent
report
trial
zinc
glucon
administ
nasal
gel
support
find
addit
shown
treatment
zinc
nasal
gel
effect
reduc
durat
sever
common
cold
symptom
patient
establish
ill
conclus
clinic
trial
data
support
valu
zinc
reduc
durat
sever
symptom
common
cold
administ
within
hour
onset
common
cold
symptom
addit
clinic
laboratori
evalu
warrant
defin
role
ionic
zinc
prevent
treatment
common
cold
elucid
biochem
mechan
zinc
exert
symptomreliev
effect
common
cold
one
frequent
ill
among
human
estim
billion
cold
occur
annual
unit
state
accord
survey
approxim
million
case
common
cold
requir
medic
attent
year
million
occur
individu
age
year
preschoolag
children
averag
five
seven
cold
year
compar
two
four
cold
annual
adult
common
cold
signific
socioeconom
impact
account
annual
million
day
miss
work
million
day
miss
school
million
day
restrict
activ
approxim
billion
expenditur
physician
visit
among
viral
etiolog
agent
implic
common
cold
differ
serotyp
rhinovirus
rhinovirus
account
respiratori
ill
autumn
caus
upper
respiratori
infect
corona
virus
caus
upper
respiratori
infect
respiratori
syncyti
viru
parainfluenza
virus
adenovirus
caus
infect
rhinoviru
infect
begin
entri
viru
anterior
nasal
mucosa
mucou
membran
eye
transport
mucociliari
action
posterior
nasopharynx
invas
nasal
mucos
epithelium
viru
replic
rapidlyproduc
symptom
within
hour
vitro
effect
zinc
zn
ion
role
treatment
common
cold
research
extens
zn
ion
known
astring
properti
loos
bound
complex
hydrat
zn
ion
zinc
acet
zinc
chlorid
astring
wherea
tightli
bound
lipophil
zinc
complex
benefici
effect
zn
appear
take
place
exclus
cell
membran
zn
reduc
permeabl
cell
membran
without
penetr
damag
cell
like
astring
zn
alter
capillari
epithelium
thu
inhibit
transcapillari
movement
plasma
protein
reduc
local
edema
inflamm
exud
mucu
secret
rhinoviru
transmit
suscept
host
either
direct
contact
larg
particl
aerosol
entri
rhinoviru
nasal
epithelium
mediat
bind
cellular
receptor
intercellular
adhes
rhinoviru
protein
capsid
contain
four
viral
protein
arrang
symmetr
pattern
deep
canyon
descend
surfac
outer
end
narrow
wedgeshap
segment
reach
bind
side
chain
canyon
floor
rhinoviru
allow
viru
penetr
cell
replic
also
play
role
inflammatori
process
tcellmedi
host
defens
system
use
receptor
leukocyt
functionassoci
antigen
bind
leukocyt
initi
sustain
inflamm
exact
biochem
immunolog
virolog
basi
action
zinc
common
cold
elucid
howev
lead
hypothesi
zn
competit
inhibitor
rhinoviru
particl
nasal
epithelium
zinc
ion
small
posit
charg
sphere
affin
receptor
site
easili
reach
rhinoviru
canyon
floor
attach
receptor
site
zinc
ion
prevent
rhinoviru
bind
also
effect
enter
cell
replic
compet
receptor
site
zinc
ion
also
thought
disrupt
bind
suppress
inflamm
may
explain
reduct
inflamm
report
patient
treat
zinc
common
cold
least
one
clinic
trial
zinc
common
cold
correl
plasma
level
zinc
proinflammatori
cytokin
synopsi
laboratori
clinic
evid
support
medicin
valu
zinc
treatment
common
cold
earli
studi
report
inconsist
find
often
design
lozeng
content
inconsist
three
recent
clinic
trial
similar
studi
design
methodolog
efficaci
assess
provid
evid
zinc
effect
significantli
shorten
durat
common
cold
administ
within
hour
onset
symptom
addit
report
trial
zinc
glucon
administ
nasal
gel
support
find
analysi
zinc
prepar
wide
avail
promot
treatment
common
cold
pharmacist
advis
patient
begin
zinc
treatment
first
sign
cold
symptom
ideal
within
hour
onset
zinc
product
continu
symptom
resolv
otherwis
advis
physician
pharmacist
reassur
patient
use
zinc
dosag
consist
product
label
safe
advers
effect
mild
gener
confin
gastrointestin
tract
zinc
formul
common
cold
systemat
studi
pregnant
lactat
femal
effect
product
contain
ionic
zinc
reduc
symptom
sever
durat
common
cold
may
depend
formul
zinc
rout
administr
research
show
efficaci
conting
use
ionic
form
zinc
zn
ion
must
deliv
nasal
mucosa
reach
maintain
contact
receptor
site
zinc
ion
readili
adsorb
mucou
membran
oropharyng
caviti
appli
directli
tissu
potenti
medicin
valu
zinc
explor
laboratori
clinic
trial
sever
formul
zinc
develop
treatment
common
cold
trial
summar
tabl
maintain
ionic
avail
zinc
challeng
formul
effect
zinc
product
zinc
offens
metal
tast
mask
properti
flavor
chelat
agent
ad
product
howev
mask
unpleas
tast
zinc
reduc
concentr
ionic
zinc
product
therebi
reduc
efficaci
recent
develop
oral
zinc
product
formul
provid
high
level
ionic
zinc
tissu
affin
pleasanttast
base
zinc
acet
glucon
lozeng
evalu
clinic
patient
common
cold
sinc
recent
research
theoriz
rhinoviru
replic
take
place
nasal
mucosa
zinc
efficaci
common
cold
resid
abil
inhibit
viral
replic
intranas
administr
zinc
may
optim
effect
zinc
cold
symptom
intranas
prepar
zn
ionsnas
spray
gel
formulationshav
evalu
determin
whether
direct
deliveri
ionic
zinc
site
viral
infect
may
effect
oral
prepar
result
first
clinic
trial
intranas
zinc
common
cold
report
effect
lozeng
intranas
zinc
formul
durat
sever
symptom
common
cold
evalu
numer
clinic
trial
random
doubleblind
placebocontrol
studi
ebi
associ
first
studi
zinc
tablet
formul
dissolv
mouth
find
show
ionic
zinc
significantli
shorten
durat
cold
reduc
sever
symptom
howev
unflavor
zinc
glucon
unpalat
led
high
patient
dropout
rate
sever
year
later
alnakib
et
al
found
zinc
glucon
lozeng
flavor
sugar
base
releas
mg
element
zinc
effect
prophylaxi
treatment
induc
rhinoviru
cold
small
group
volunt
subsequ
number
group
conduct
trial
patient
experiment
induc
natur
cold
use
flavor
agent
strong
complex
compon
citric
acid
tartar
acid
mannitolsorbitol
howev
formul
result
highli
bound
zinc
complex
releas
littl
ionic
zinc
mouth
trial
unabl
demonstr
treatment
effect
differ
placebo
lozeng
addit
sever
trial
consid
flaw
use
rel
low
dose
mg
zinc
faulti
methodolog
specul
lack
effect
zinc
earli
studi
result
inactiv
chelat
agent
research
develop
formul
readili
releas
zinc
ion
complex
evalu
clinic
trial
first
godfrey
et
al
found
zinc
glucon
hard
candi
base
element
zinc
mg
use
everi
hour
awak
significantli
reduc
durat
cold
sever
symptom
anoth
key
find
studi
zinc
reduc
durat
cold
addit
day
p
treatment
initi
within
hour
onset
cold
symptom
result
studi
godfrey
et
al
corrobor
three
five
studi
publish
next
year
compar
studi
design
earlier
trial
three
studi
use
zinc
glucon
zinc
acet
lozeng
mg
mg
element
zinc
calcium
lactat
dextros
base
enrol
patient
use
scale
rate
symptom
sever
none
mild
moder
sever
began
treatment
within
hour
symptom
onset
virtual
ident
dosag
regimen
lozeng
everi
hour
long
symptom
persist
zinc
consist
significantli
reduc
durat
cold
durat
cold
symptom
three
studi
durat
cold
reduc
day
p
p
two
random
placebocontrol
studi
fail
find
consist
signific
differ
zinc
placebo
durat
cold
durat
cold
symptom
studi
differ
consider
methodolog
three
studi
show
signific
differ
zinc
placebo
treatment
exampl
studi
turner
cetnarowski
evalu
zinc
glucon
element
zinc
mg
zinc
acet
element
zinc
mg
lozeng
adult
induc
natur
cold
zinc
glucon
significantli
reduc
durat
induc
cold
compar
placebo
p
sever
cold
symptom
neither
zinc
formul
affect
durat
sever
natur
cold
zinc
acet
lozeng
may
formul
base
contain
plantderiv
oil
high
temperatur
use
manufactur
lozeng
may
caus
oil
react
posit
charg
zinc
ion
yield
fat
complex
incap
releas
zn
ion
inconsist
result
zinc
lozeng
coupl
uncertain
mechan
action
ionic
zinc
led
research
explor
deliveri
zn
ion
directli
nasal
mucosa
site
rhinoviru
infect
earli
intranas
spray
formul
contain
zinc
zinc
sulfat
element
zinc
mg
per
dose
given
two
inhal
nostril
four
time
daili
symptom
resolv
clinic
trial
formul
random
doubleblind
placebocontrol
studi
patient
enrol
within
hour
symptom
onset
symptom
evalu
scale
differ
zinc
nasal
spray
placebo
spray
median
durat
symptom
median
durat
nasal
symptom
post
hoc
analysi
found
adjust
differ
baselin
symptom
sever
zinc
spray
significantli
reduc
total
symptom
total
nasal
symptom
score
day
total
maximum
daili
dose
zinc
deliv
prepar
mg
may
low
effect
evalu
intranas
zinc
gel
random
doubleblind
trial
publish
intranas
gel
formul
consist
mm
ionic
zinc
emuls
ph
deliv
microlit
per
spray
nasal
gel
spray
investig
three
random
doubleblind
placebocontrol
studi
two
treatment
natur
cold
one
prophylaxi
treatment
induc
cold
design
first
studi
hirt
et
al
similar
evalu
zinc
glucon
lozeng
mossad
et
al
patient
group
treat
either
nasal
gel
spray
placebo
begin
less
hour
onset
cold
symptom
rate
symptom
scale
twice
daili
instruct
use
zinc
nasal
gel
everi
hour
awak
longer
experienc
symptom
use
efficaci
endpoint
complet
resolut
symptom
investig
found
durat
symptom
patient
treat
zinc
nasal
gel
day
compar
day
placebo
group
differ
day
p
reduct
durat
symptom
consist
report
preliminari
studi
nasal
gel
formul
patient
treat
within
hour
onset
symptom
studi
turner
evalu
prophylact
effect
intranas
zinc
glucon
healthi
volunt
treatment
consist
singl
spray
per
nostril
time
day
day
prior
rhinoviru
inocul
day
afterward
patient
develop
rhinoviru
infect
follow
inocul
administr
nasal
gel
effect
total
nasal
symptom
score
result
recent
clinic
trial
zinc
nasal
gel
formul
report
mossad
trial
demonstr
nasal
gel
formul
deliv
total
daili
dose
element
zinc
mg
effect
administ
cold
symptom
present
hour
studi
hirt
et
al
patient
use
nasal
gel
four
time
day
symptom
resolv
rate
symptom
scale
twice
daili
zinc
nasal
gel
significantli
reduc
median
durat
symptom
day
placebo
day
differ
day
p
treatment
spray
gel
also
significantli
reduc
time
resolut
one
cold
symptom
day
p
addit
effect
symptom
durat
zinc
nasal
gel
also
significantli
reduc
time
resolut
nasal
drainag
congest
hoars
sore
throat
day
p
score
nasal
symptom
patient
treat
zinc
nasal
gel
significantli
lower
patient
treat
placebo
nasal
gel
day
similarli
score
throat
symptom
significantli
lower
day
seriou
advers
event
report
clinic
trial
use
either
zinc
lozeng
zinc
nasal
gel
treatment
common
cold
common
advers
effect
clinic
trial
lozeng
nasal
spray
formul
includ
headach
dri
mouth
andor
throat
tast
alter
nasal
irrit
burn
mild
gastrointestin
complaint
studi
zinc
nasal
gel
formul
type
incid
advers
effect
similar
zinc
placebo
group
nasal
tingl
sting
burn
sensat
frequent
report
advers
event
patient
report
case
dri
mouth
throat
alter
sens
tast
although
isol
anecdot
report
lay
media
alleg
associ
use
zinc
nasal
gel
onset
anosmia
clinic
trial
intranas
zinc
glucon
gel
singl
report
lost
diminish
smell
least
instanc
associ
base
find
studi
evalu
nasal
administr
entir
differ
compoundzinc
sulfatefor
polio
prevent
zinc
sulfat
miner
salt
react
water
produc
sulfur
acid
zinc
oxid
comparison
zinc
glucon
weak
organ
salt
dissolv
form
posit
charg
zinc
ion
neg
charg
gluconatea
natur
occur
nontox
compound
found
human
tissu
rhinovirus
believ
primari
etiolog
agent
common
cold
receptor
present
nasal
epithelium
rhinoviru
structur
attach
rhinoviru
endotheli
cell
produc
inflamm
immunolog
respons
characterist
common
cold
propos
mechan
action
ionic
zinc
competit
receptor
prevent
rhinoviru
attach
replic
nasal
epitheli
cell
reduct
inflamm
nasal
tissu
doubleblind
random
placebocontrol
clinic
trial
inconsist
find
regard
effect
zinc
glucon
acet
lozeng
howev
two
welldesign
trial
provid
evid
zinc
glucon
shorten
durat
common
cold
administ
within
hour
onset
symptom
inconsist
result
like
attribut
reduct
efficaci
zinc
secondari
chang
formul
effort
mask
unpleas
properti
zinc
recent
report
demonstr
treatment
zinc
nasal
gel
effect
reduc
durat
sever
common
cold
symptom
within
hour
symptom
onset
zinc
prepar
wide
avail
retail
outlet
promot
gener
public
pharmacist
like
receiv
inquiri
patient
regard
safeti
efficaci
zinc
common
cold
discuss
report
evid
exist
support
therapeut
effect
zinc
start
earli
cours
cold
ideal
prodrom
period
pharmacist
reassur
patient
zinc
safeti
use
dosag
consist
product
label
advers
effect
mild
gener
confin
gastrointestin
tract
patient
counsel
begin
zinc
first
sign
cold
symptom
ideal
within
hour
onset
cold
symptom
zinc
product
continu
symptom
resolv
otherwis
advis
physician
zinc
formul
common
cold
systemat
studi
pregnant
lactat
femal
ohio
scio
colleg
pharmaci
chemistri
affili
methodist
episcop
church
america
addit
pharmaci
cours
busi
music
elocut
public
speak
offer
